Pegasus Partners Ltd. Cytosorbents Corp Transaction History

Pegasus Partners Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 24, 2019	SELL	$4.33 - $7.63 $43,300 - $76,300	-10,000 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$7.05 - $12.64 $1,515 - $2,717	-215 Reduced 2.1%	10,000 $81,000
Q3 2018 Nov 07, 2018	BUY	$10.95 - $14.8 $2,354 - $3,182	215 Added 2.15%	10,215 $132,000
Q2 2018 Jul 27, 2018	BUY	$6.9 - $12.35 $69,000 - $123,500	10,000 New	10,000 $114,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Pegasus Partners Ltd. with notifications on news.